Skip to main content
. 2021 Nov 18;42(6):800–824. doi: 10.24272/j.issn.2095-8137.2021.251

Table 2. Genetic animal models targeting classical ASD risk genes.

Genes Neuronal function Clinical relevancea Rescue agentc References
Typical symptoms Animal performancesb
Genetic Pharmaceutical
a: M: Monkey; R: Rodents; F: Fish; I: Invertebrates. b: ①: Social communication disorders; ②: Repetitive/stereotyped behaviors; ③: Narrow interests; ④: Impaired linguistics; ⑤: Intellectual disability. +: Positive, –: Negative. c: Based on the public data from SFARI GENE: https://gene.sfari.org/database/animal-models/rescue-animal-models.
Syndromic
MECP2 Starts or inhibits transcription; neuron maturation; regulated by development + + + + + M + + + + One copy knocked out of Crh, or Crhr1, or Oprm; Reducing Mecp2 expression from a transgene, MECP2-dNIC; Reinstatement of Mecp2 7,8-Dihydroxyflavone; Acetyl-L-carnitine; D-Cycloserine; CX546; Antalarmin; Cysteamine; RU-486; Isoguvacine; Midazolam; Fenobam; SCH-23390; SCH-39166 Achilly et al., 2021; Zhan et al., 2021
R + + + + +
F + + + +
I + + + +
FMR1 Involves in translation; affects neuronal proliferation and migration + + + + + R + + + + + Inactivation of one allele of App gene; inactivation of one copy of S6K1; inactivation of S6K1 gene Cyclosporine-A; Dexpramipexole; Isoguvacine; CTEP; Bryostatin1; MPEP; BW-723C86; MDL-11,939; JQ1; Sulpiride; CX-4945, Recombinant IL-17a, Lithium; Minocycline; Lipopolysaccharide; Bumetanide; FRAX486 Dockendorff et al., 2002; Kim et al., 2014b; Reynolds et al., 2021; Schiavi et al., 2020
F + + + +
I + + + +
SHANK3 Promotes formation, maturation, and stability of dendritic spines + + + + + M + + + + Reinstatement of Shank3; beta-catenin shRNA; constitutively active Rac1 CDPPB; MPEP; Insulin-like growth factor 1 and its peptide derivative; CX-546; Lipopolysaccharide; Cocaine; Isoguvacine; D-Cycloserine; 7,8-Dihydroxyflavone; TG003; Valproic acid; Aripiprazole; Clozapine; Romidepsin; Fluoxetine; Phospho-cofilin peptide; Oxytocin; Risperidone; Trichostatin A Han et al., 2013; Kozol et al., 2015; Liu et al., 2018; Matas et al., 2021; Mossa et al., 2021
R + + + + +
F + + + +
I + + + +
TSC1/2 Regulates mTORC1 pathway, neuronal differentiation, and Purkinje cell excitability + + + + + R + + + + + D-Cycloserine, Fenobam, SCH-23390, SCH-39166, Rapamycin Normand et al., 2013; Tsai et al., 2012
UBE3A Regulates neuronal homeostatic synaptic plasticity + + + + + R + + + + Reinstatement of Ube3a in GABAergic neurons Cbln1 expression; THIP; Pamin Krishnan et al, 2017; Xu et al, 2018
Non-syndromic
NLGNs Regulates the formation of hippocampal neurons and post-glutamatergic synapse proteins + + + + + R + + + + + Nlgn3,shRNAs against Nlgn1,shRNAs against Nlgn2,DIO-NL3 transgene in nucleus accumbens,Optogenetic activation of Pvalb interneurons, Nlgn3 reexpression ETC-168, ACEA, HU-210, Quinpirole, URB597 Camacho et al., 2014; Kolozsi et al., 2009; Sledziowska et al., 2020
NRXNs Encodes neuronal transmembrane protein; interacts glial cells + + + + + R + + + + + Etherton et al., 2009; Tromp et al., 2021
CHD8 Controls epigenetic and transcript regulation; affects brain phenotype + + + + + R + + + + Human CHD8; stabilized Ctnnb1(S37A) CPI-455; Oxytocin Kunkel et al, 2018; Platt et al, 2017; Sugathan et al, 2014
F
POGZ Regulates neuronal development + + + + + R + + + NBQX; Oxytocin; Perampanel Matsumura et al, 2020; Suliman-Lavie et al, 2020; White et al, 2016
ANK2 Affects axonal branching; regulates postnatal development of excitatory synapses + + + R + + + Iossifov et al, 2014; Sztainberg et al, 2016
MIR137 Regulates neuronal gene expression and neurogenesis + + + + + R + + + Ablation of Pde10a Papaverine Cheng et al., 2018
16p11.2 Controls prefrontal connectivity; endothelium-dependent structural and functional neurovascular + + + + + R + + + + + Portmann et al, 2014; Yin et al, 2021
F